Rolf Rau
Department of Rheumatology
Evangelisches Fachkrankenhaus Ratingen
Germany
Name/email consistency: high
- Have traditional DMARDs had their day? Effectiveness of parenteral gold compared to biologic agents. Rau, R. Clin. Rheumatol. (2005)
- Rapid alleviation of signs and symptoms of rheumatoid arthritis with intravenous or subcutaneous administration of adalimumab in combination with methotrexate. Rau, R., Simianer, S., van Riel, P.L., van de Putte, L.B., Krüger, K., Schattenkirchner, M., Allaart, C.F., Breedveld, F.C., Kempeni, J., Beck, K., Kupper, H. Scand. J. Rheumatol. (2004)
- Erosion healing in rheumatoid arthritis after anakinra treatment. Rau, R., Sander, O., Wassenberg, S. Ann. Rheum. Dis. (2003)
- Adalimumab (a fully human anti-tumour necrosis factor alpha monoclonal antibody) in the treatment of active rheumatoid arthritis: the initial results of five trials. Rau, R. Ann. Rheum. Dis. (2002)
- Identification of radiologic healing phenomena in patients with rheumatoid arthritis. Rau, R., Wassenberg, S., Herborn, G., Perschel, W.T., Freitag, G. J. Rheumatol. (2001)
- The effect of HLA-DRB1 genes, rheumatoid factor, and treatment on radiographic disease progression in rheumatoid arthritis over 6 years. Rau, R., Herborn, G., Zueger, S., Fenner, H. J. Rheumatol. (2000)